Medicines & drugs recalls
909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.
Page 14 of 19
- Mylan-Cinacalcet: Affected lots exceed the established acceptable intake limit for N-nitroso-cinacalcet.Health CanadaProduct quality
- KABANA SKIN CARE recalls GreenScreen and 3 moreFDACGMP deviations
- Macleods Pharmaceuticals Ltd recalls Famciclovir TabletsFDAPresence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.
- Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
- Taro-Doxorubicin Liposomal: may contain particulate matterHealth CanadaProduct quality
- Twin Rivers Farm Ltd. recalls one lot of Surf Banana Split dried cannabis pre-rolls, one lot of Surf Layer Cake dried cannabis pre-rolls, and one lot of Surf Mac dried cannabis pre-rollsHealth CanadaLabelling and packaging
- Apo-Dutasteride 0.5 mg: Affected lot may contain undersized capsulesHealth CanadaProduct quality
- Tailstorm Health INC recalls KETAmine Hydrochloride Injection and 3 moreFDALack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
- Church & Dwight Inc recalls Orajel Baby and 2 moreFDAMicrobial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.
- Orient Pharma Co., Ltd. Yunlin Plant recalls Pitavastatin TabletsFDAFailed Impurities/Degradation Specifications.
- The Harvard Drug Group LLC recalls Gabapentin CapsulesFDADefective container; blister packaging inadequately sealed.
- Granules Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-Release TabletsFDAFailed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH)…
- Sandoz Inc recalls Cefazolin for Injection and 1 moreFDALabeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection,…
- AvKARE recalls Pitavastatin TabletsFDAFailed Impurity/Degradation Specifications
- NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tabletsHealth CanadaProduct safety
- Anesketin : Presence of particulate matter in the affected lotsHealth CanadaProduct quality
- PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidateHealth CanadaProduct quality
- RIVA-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineHealth CanadaProduct quality
- Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) recalls Semaglutide and 8 moreFDALack of Assurance of Sterility
- Fresenius Medical Care Holdings, Inc. recalls .9% Sodium Chloride InjectionFDALack of Assurance of Sterility
- Teva Pharmaceuticals USA, Inc recalls Metoclopramide TabletsFDAPresence of foreign tablets/capsules.
- Pfizer Inc. recalls DOBUTamine InjectionFDADiscoloration; discolored solution from cracked vials
- Apotex Corp. recalls Ketorolac Tromethamine Ophthalmic Solution and 2 moreFDALack of Assurance of Sterility
- Advanced Pharmaceutical Technology, Inc. recalls TESTO-200FDAMarketed Without an Approved NDA/ANDA
- B BRAUN MEDICAL INC recalls .9% Sodium Chloride Injection USPFDALack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
- PMS-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineHealth CanadaProduct quality
- Dr. Nutrition 360 Magnesium 200 mg capsule; Incorrect non-medicinal ingredient (Gelatin)Health CanadaProduct quality
- PRO-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineHealth CanadaProduct quality
- Yi Li Xiao Capsule; Undeclared prescription drug (Tadalafil)Health CanadaProduct quality
- Aurobindo Pharma USA Inc recalls Acetaminophen TabletsFDACGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).
- Umary-USA.com recalls UNAVY ACIDO HIALURONICO and 1 moreFDAMarketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and…
- Eugia US LLC recalls Gentamicin InjectionFDAFailed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
- Gamunex solution; may cause allergic / hypersensitivity type reactionHealth CanadaAdverse reaction
- Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.Health CanadaProduct quality
- Teva-Piroxicam 10 mg capsule; Out of specification (Dissolution)Health CanadaProduct quality
- SAINI TRADE INC recalls ELECTRO BUZZ and 4 moreFDAMarketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared chloropretadalafil,…
- Alembic Pharmaceuticals Limited recalls Celecoxib CapsulesFDAPresence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule
- AvKARE recalls Chlorthalidone TabletsFDAFailed Dissolution Specifications
- Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin TabletsFDAFailed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time…
- AvKARE recalls Celecoxib CapsulesFDAPresence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg…
- Ascend Laboratories, LLC recalls Cephalexin for Oral SuspensionFDAFailed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of…
- Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules 1 gramFDAFailed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation…
- Macleods Pharmaceuticals Ltd recalls Levothyroxine Sodium TabletsFDAPresence of a foreign substance: black hair found embedded in tablet.
- Amneal Pharmaceuticals, LLC recalls Sulfamethoxazole and Trimethoprim TabletsFDAMicrobial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
- Weiteling tablet; Missing medical ingredient Bletilla striata & incorrect expiry dateHealth CanadaProduct quality
- JuHong TanKe JianGao liquid; missing medicinal ingredient "Glycyrrhiza uralensis" on labelHealth CanadaProduct quality
- Kimmtrak Solution; Out of specification (in-vitro potency assay)Health CanadaProduct quality
- Amerisource Health Services LLC recalls Indomethacin Extended-Release CapsulesFDACGMP deviations
- Apotex Corp. recalls Lacosamide Oral SolutionFDADefective Container: This recall is being initiated due to a leaking unit stored horizontally.
- Consumer Product Partners, LLC recalls Spectrum Advanced Gel Hand SanitizerFDASubpotent product: Product has cloudy appearance and tested below assay label claim for 70% Ethyl Alcohol